Preclinical characterization of abemaciclib in hormone receptor positive breast cancer

Raquel Torres-Guzmán(Eli Lilly (Spain)), Marı́a José Lallena(Eli Lilly (Spain))
Oncotarget
May 10, 2017
Cited by 196


Related Papers

No related papers found

Powered by citation graph analysis